Related Experiment Videos
Maternal phenylketonuria. Review with emphasis on pathogenesis
1Children's Hospital, Boston, Mass.
Enzyme
|January 1, 1987
Summary
Maternal phenylketonuria (PKU) can cause fetal developmental issues. Early dietary phenylalanine restriction before conception protects the fetus, but delaying treatment during pregnancy offers less protection.
Area of Science:
- Biochemistry
- Developmental Biology
- Genetics
Background:
- Maternal phenylketonuria (PKU) poses significant risks to fetal development.
- Affected offspring often exhibit microcephaly, intellectual disability, congenital heart defects, and low birth weight.
Purpose of the Study:
- To review the impact of maternal PKU on fetal development.
- To assess the efficacy of phenylalanine-restricted diets in mitigating these effects.
Main Methods:
- Review of existing literature on maternal PKU and its outcomes.
- Analysis of studies involving dietary interventions before and during pregnancy.
- Examination of animal models of hyperphenylalaninemia.
Main Results:
- Dietary treatment initiated before conception significantly protects the fetus.
- Delayed dietary intervention during pregnancy provides limited fetal protection.
- Animal models show reduced fetal growth and potential learning impairments, but do not fully replicate the human syndrome.
Conclusions:
- Early dietary management is crucial for preventing fetal complications in maternal PKU.
- The precise mechanism of fetal damage in maternal PKU remains unclear, despite phenylalanine's suspected role.